<DOC>
	<DOCNO>NCT01913340</DOCNO>
	<brief_summary>Hypoxic-ischemic encephalopathy ( HIE ) , condition reduce blood oxygen flow baby 's brain near time birth , may cause death neurologic disability . Cooling therapy ( hypothermia ) provide protection , half affect infant still poor outcome . This clinical trial determine drug erythropoietin , give hypothermia , safe use treatment may reduce risk neurologic deficit HIE .</brief_summary>
	<brief_title>Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Newborn Brain Injury ( NEATO )</brief_title>
	<detailed_description>This phase I/II clinical trial design demonstrate : 1 . The feasibility recruiting , enrol follow 50 patient moderate severe HIE 5 site , meet specify recruitment follow-up target goal . 2 . The safety high-dose Epo therapy neonates HIE respect systemic organ function general growth parameter . 3 . The value brain MRI/MRS perform 4-7 day age biomarker motor function 12 month age .</detailed_description>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Hypoxia-Ischemia , Brain</mesh_term>
	<mesh_term>Asphyxia</mesh_term>
	<mesh_term>Asphyxia Neonatorum</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Newborns ≥ 36 week gestation , &lt; 23 hour age time consent , must meet 3 Inclusion Criteria eligible study : 1 . Perinatal depression = least one following : ) Apgar ≤5 10 min b ) require resuscitation ( endotracheal mask ventilation , chest compression ) 10 min c ) pH &lt; 7.0 base deficit ≥15 cord , arterial , venous blood obtain &lt; 60 min age ; 2 . Moderate severe encephalopathy = least 3 6 modify Sarnat criterion present 16 h birth : ) reduce level consciousness ; b ) decrease spontaneous activity ; c ) hypotonia ; ) decrease suck ; e ) decrease Moro reflex ; f ) respiratory distress include periodic breathing apnea ; 3 . Hypothermia = passive active cooling begin 6 hour age . Intrauterine growth restriction ( BW &lt; 1800 g ) ; Major congenital malformation ; suspect genetic syndrome , metabolic disorder TORCH infection ; Head circumference &lt; 2 SD gestation ; Infant withdrawal supportive care consider ; Anticipated inability collect primary endpoint 12 month age .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>erythropoietin</keyword>
	<keyword>therapeutic hypothermia</keyword>
</DOC>